Vanguard Group Inc Nexgel, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Nexgel, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 68,650 shares of NXGL stock, worth $167,506. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,650
Previous 50,102
37.02%
Holding current value
$167,506
Previous $149,000
18.79%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NXGL
# of Institutions
19Shares Held
721KCall Options Held
0Put Options Held
0-
Evernest Financial Advisors, LLC Carmel, IN281KShares$685,6400.26% of portfolio
-
Morgan Stanley New York, NY122KShares$296,5910.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.4KShares$161,9400.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny54.8KShares$133,7870.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA38KShares$92,7510.02% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $13.6M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...